D
Daan Gene Co Ltd
SZSE:002030
Daan Gene Co Ltd
SZSE:002030
Price:
6.3
CNY
-1.56%
Market Closed
Market Cap:
¥8.8B
Relative Value
The Relative Value of one Daan Gene Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 6.3 CNY, Daan Gene Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Daan Gene Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Daan Gene Co Ltd Competitors
Daan Gene Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
D
|
Daan Gene Co Ltd
SZSE:002030
|
8.8B CNY | 11.6 | -15.7 | -10.9 | -10.9 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
397.3B USD | 6.7 | 169.2 | 16.4 | 23.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.9B USD | 5.6 | 26.5 | 15.1 | 15.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
178.6B USD | 6.1 | 21 | 14.2 | 14.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.7B USD | 10.1 | 30.7 | 23.5 | 24.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
81.1B USD | 5.7 | 18 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.2 | 16.7 | 11.4 | 14.3 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.9B EUR | 13.2 | 31 | 52.7 | 54.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
